Excitability as a core design principle unifies immune system responses to pathogens, autoimmunity, and tumors

The field of immunology has accumulated vast knowledge, yet unifying concepts explaining how molecular circuits achieve critical immune goals remain elusive. These goals include mounting a strong response to pathogens, maintaining self-tolerance, and preventing collateral damage. Current models often struggle to integrate these diverse requirements into a cohesive framework, leaving a gap in our fundamental understanding of immune system design. This research proposes 'excitability' as a principle to bridge this conceptual divide.

Researchers mathematically screened thousands of cytokine and cell circuits to identify those exhibiting excitability. The study's primary endpoint was to find circuits that produce a large, self-limiting response pulse when a stimulus crosses a threshold, followed by a refractory period. They then analyzed these identified circuits for Pareto optimality in terms of speed and strength. The computational model compared the performance of various circuit designs against suboptimal alternatives, assessing their ability to generate robust and controlled immune responses.

The mathematical screening identified a handful of cytokine and cell circuits capable of exhibiting excitability. Of these, a single robust circuit was found to be Pareto optimal for both speed and strength. This optimal circuit design involves an effector that induces itself and simultaneously induces its inhibitor, creating a self-regulating feedback loop. Crucially, this specific circuit architecture appears dozens of times within the human immune network, suggesting its widespread importance, whereas suboptimal excitable circuits were not observed. The identified excitable circuit provides a unifying explanation for diverse immune phenomena, including the dynamics of responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the mechanisms underlying autoimmune flares, and the complex interplay in tumor immunity. This suggests a fundamental, conserved design principle across various immune contexts. The model successfully explains existing data in these areas, offering a consistent framework for understanding immune circuit behavior. The authors found that this specific circuit configuration is uniquely suited to balance the need for a rapid, strong response with the necessity for self-limitation and refractory periods, essential for preventing chronic inflammation and maintaining homeostasis.